Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Avalox
Also marketed in the EU under the name(s): Avelox, Izilox, Muzolil
Active substance: moxifloxacin hydrochloride
Indication: Avalox is indicated for the treatment of community acquired pneumonia (CAP), complicated skin and skin structure infections (cSSSI)
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2009 Referral EMEA/H/A-29/1082 (2009)7710 of 02/10/2009